Events & Presentations
Upcoming Events
| Date | Event Details | Remind Me |
|---|---|---|
|
Aug 5, 2021 4:30 PM EDT
|
Arrowhead Pharmaceuticals 2021 Third Quarter Results
|
Archived Events
| Date | Event Details |
|---|---|
|
Jun 10, 2020 11:20 AM EDT
|
Goldman Sachs 41st Annual Global Healthcare Conference
Dr. Anzalone will participate in a fireside chat presentation
|
|
Jun 4, 2020 2:00 PM EDT
|
Jefferies 2020 Healthcare Conference
Chris Anzalone, Ph.D., Arrowhead’s president and CEO, will participate in a fireside chat presentation
|
|
May 20, 2020 2:30 PM EDT
|
RBC Global Healthcare Conference
Dr. Anzalone will participate in a fireside chat presentation
|
|
May 14, 2020 11:00 AM EDT
|
BofA Securities 2020 Health Care Conference
Chris Anzalone, Ph.D., Arrowhead’s president and CEO, will deliver corporate presentation |
|
May 7, 2020 4:30 PM EDT
|
Arrowhead Pharmaceuticals 2020 Second Quarter Results
Prepared Remarks 210.2 KB
|
|
Mar 18, 2020 4:00 PM EDT
|
Oppenheimer 30th Annual Healthcare Conference
New York
Conference Presentations cancelled due to COVID-19 |
|
Mar 17, 2020 2:00 PM EDT
|
5th Annual Oligonucleotide & Precision Therapeutics Congress
Cambridge
Conference Presentations cancelled due to COVID-19 |
|
Mar 11, 2020 11:15 AM EDT
|
Barclays Global Healthcare Conference
Miami
Bruce Given, M.D., Arrowhead’s chief operating officer and head of R&D, will participate in a hybrid podium/fireside chat presentation
|
|
Feb 5, 2020 4:30 PM EST
|
Arrowhead Pharmaceuticals 2020 First Quarter Results
|
|
Dec 10, 2019 6:00 PM HST
|
HEP DART 2019
View Presentation 6.4 MB
Bruce Given, M.D., Arrowhead’s chief operating officer and head of R&D, will deliver an oral presentation titled, “Where will RNAi fit in the era of finite therapies” |